Related Experiment Video
Updated: May 24, 2026
05:52
Sentinel Lymph Node Mapping and Biopsy for Endometrial Cancer at Early Stage with Laparoscopy
Published on: August 19, 2021
Advances in sentinel lymph node mapping for patients with melanoma
1Department of Surgery, Memorial Sloan-Kettering Cancer Center, Weill-Cornell School of Medicine, New York, NY, USA. bradym@mskcc.org
Future Oncology (London, England)
|February 17, 2012
Summary
Sentinel lymph node biopsy provides accurate staging for cutaneous melanoma patients with normal lymph nodes. The prognostic information gained outweighs the procedure
Area of Science:
- Oncology
- Surgical Pathology
- Dermatology
Background:
- Cutaneous melanoma staging is critical for treatment planning.
- Sentinel lymph node (SLN) mapping offers accurate pathological staging.
- SLN biopsy is indicated for patients with clinically normal regional nodes.
Purpose of the Study:
- To evaluate the role of sentinel lymph node mapping in staging cutaneous melanoma.
- To assess the prognostic value of SLN biopsy.
- To weigh the benefits against the risks of the procedure.
Main Methods:
- Sentinel lymph node mapping techniques.
- Pathological staging of regional lymph nodes.
- Analysis of procedural morbidity and prognostic data.
Main Results:
- Sentinel lymph node mapping enables precise pathological staging in melanoma.
- The procedure has gained widespread surgical acceptance due to technical advances.
- Morbidity is known, but prognostic benefits are significant.
Conclusions:
- Sentinel lymph node biopsy is a valuable tool for staging cutaneous melanoma.
- The prognostic information from SLN biopsy outweighs procedural risks for most intermediate-risk patients.
- Widespread adoption is supported by technical advancements and clinical utility.
